Status:
TERMINATED
Ultrasound Evaluation of Crohn's Disease
Lead Sponsor:
Mayo Clinic
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.
Detailed Description
The investigators will study the efficacy of ultrasound shear wave elastography and vascularity imaging for Crohn's Disease (CD) evaluation. Literature evidences demonstrate that bowel stiffness is co...
Eligibility Criteria
Inclusion
- \- Crohn's disease patients with involvement of terminal ileum (thickness \> 3mm).
Exclusion
- Patients with change of medicine or going to surgery over the 6-months follow-up period.
- Patients with unreliable ultrasound images due to conditions such as large body habitus or poor ultrasound imaging window.
- Adults lacking capacity to consent.
- Vulnerable subjects such as prisoners.
- Pregnant women and nursing mothers.
- Patients with known or suspected right-to-left, bi-directional, or transient right-to-left cardiac shunts.
- Patients with history of hypersensitivity allergic reactions to ultrasound contrast agents.
Key Trial Info
Start Date :
June 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2021
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03235180
Start Date
June 16 2017
End Date
October 12 2021
Last Update
November 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55902